Comino Garcia-Munoz A, Varlet I, Grau G, Perles-Barbacaru T, Viola A
Pathogens. 2025; 13(12.
PMID: 39770302
PMC: 11728472.
DOI: 10.3390/pathogens13121042.
Batarseh A, Vafaee F, Hosseini-Beheshti E, Safarchi A, Chen A, Cohen A
Int J Mol Sci. 2023; 24(1).
PMID: 36613941
PMC: 9820457.
DOI: 10.3390/ijms24010501.
Gul S, Ribeiro-Gomes F, Moreira A, Sanches G, Conceicao F, Daniel-Ribeiro C
Sci Rep. 2021; 11(1):12077.
PMID: 34103601
PMC: 8187502.
DOI: 10.1038/s41598-021-91499-3.
Marin A, Murillo O, Sussmann R, Ortolan L, Battagello D, de Castro Quirino T
Antimicrob Agents Chemother. 2021; 65(5).
PMID: 33649109
PMC: 8092904.
DOI: 10.1128/AAC.00004-21.
Renia L, Grau G, Wassmer S
J Clin Invest. 2020; 130(3):1109-1111.
PMID: 32065593
PMC: 7269553.
DOI: 10.1172/JCI135510.
The Ins and Outs of Cerebral Malaria Pathogenesis: Immunopathology, Extracellular Vesicles, Immunometabolism, and Trained Immunity.
Sierro F, Grau G
Front Immunol. 2019; 10:830.
PMID: 31057552
PMC: 6478768.
DOI: 10.3389/fimmu.2019.00830.
Young Sprague Dawley rats infected by Plasmodium berghei: A relevant experimental model to study cerebral malaria.
Keita Alassane S, Nicolau-Travers M, Menard S, Andreoletti O, Cambus J, Gaudre N
PLoS One. 2017; 12(7):e0181300.
PMID: 28742109
PMC: 5524346.
DOI: 10.1371/journal.pone.0181300.
Pathophysiological Mechanisms in Gaseous Therapies for Severe Malaria.
Kayano A, Dos-Santos J, Bastos M, Carvalho L, Aliberti J, Costa F
Infect Immun. 2016; 84(4):874-882.
PMID: 26831465
PMC: 4807480.
DOI: 10.1128/IAI.01404-15.
Loss of Toll-like receptor 7 alters cytokine production and protects against experimental cerebral malaria.
Baccarella A, Huang B, Fontana M, Kim C
Malar J. 2014; 13:354.
PMID: 25192715
PMC: 4164820.
DOI: 10.1186/1475-2875-13-354.
Vascular dysfunction as a target for adjuvant therapy in cerebral malaria.
Carvalho L, Moreira A, Daniel-Ribeiro C, Martins Y
Mem Inst Oswaldo Cruz. 2014; 109(5):577-88.
PMID: 25185000
PMC: 4156451.
DOI: 10.1590/0074-0276140061.
Damage to the blood-brain barrier during experimental cerebral malaria results from synergistic effects of CD8+ T cells with different specificities.
Poh C, Howland S, Grotenbreg G, Renia L
Infect Immun. 2014; 82(11):4854-64.
PMID: 25156726
PMC: 4249313.
DOI: 10.1128/IAI.02180-14.
Lactate transport and receptor actions in cerebral malaria.
Mariga S, Kolko M, Gjedde A, Bergersen L
Front Neurosci. 2014; 8:125.
PMID: 24904266
PMC: 4032900.
DOI: 10.3389/fnins.2014.00125.
Transdermal glyceryl trinitrate as an effective adjunctive treatment with artemether for late-stage experimental cerebral malaria.
Orjuela-Sanchez P, Ong P, Zanini G, Melchior B, Martins Y, Meays D
Antimicrob Agents Chemother. 2013; 57(11):5462-71.
PMID: 23979751
PMC: 3811294.
DOI: 10.1128/AAC.00488-13.
Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria.
Howland S, Poh C, Gun S, Claser C, Malleret B, Shastri N
EMBO Mol Med. 2013; 5(7):984-99.
PMID: 23681698
PMC: 3721469.
DOI: 10.1002/emmm.201202273.
Protective role of brain water channel AQP4 in murine cerebral malaria.
Promeneur D, Lunde L, Amiry-Moghaddam M, Agre P
Proc Natl Acad Sci U S A. 2013; 110(3):1035-40.
PMID: 23277579
PMC: 3549120.
DOI: 10.1073/pnas.1220566110.
Neuroimmunological blood brain barrier opening in experimental cerebral malaria.
Nacer A, Movila A, Baer K, Mikolajczak S, Kappe S, Frevert U
PLoS Pathog. 2012; 8(10):e1002982.
PMID: 23133375
PMC: 3486917.
DOI: 10.1371/journal.ppat.1002982.
Cerebral malaria: mysteries at the blood-brain barrier.
Renia L, Howland S, Claser C, Gruner A, Suwanarusk R, Teo T
Virulence. 2012; 3(2):193-201.
PMID: 22460644
PMC: 3396698.
DOI: 10.4161/viru.19013.
Efficacy of different nitric oxide-based strategies in preventing experimental cerebral malaria by Plasmodium berghei ANKA.
Martins Y, Zanini G, Frangos J, Carvalho L
PLoS One. 2012; 7(2):e32048.
PMID: 22348145
PMC: 3278462.
DOI: 10.1371/journal.pone.0032048.
The relevance of non-human primate and rodent malaria models for humans.
Langhorne J, Buffet P, Galinski M, Good M, Harty J, Leroy D
Malar J. 2011; 10:23.
PMID: 21288352
PMC: 3041720.
DOI: 10.1186/1475-2875-10-23.
Artemether and artesunate show the highest efficacies in rescuing mice with late-stage cerebral malaria and rapidly decrease leukocyte accumulation in the brain.
Clemmer L, Martins Y, Zanini G, Frangos J, Carvalho L
Antimicrob Agents Chemother. 2011; 55(4):1383-90.
PMID: 21220531
PMC: 3067152.
DOI: 10.1128/AAC.01277-10.
